No Detail Found!

Effect of lidocaine infusion compared to dexmedetomidine infusion on proinflammatory cytokines and stress response in pelvi-abdominal cancer surgeries: a randomized clinical trial

Author(s)
Mohamed Mahmoud Hassan Department of Anesthesiology, Surgical ICU and Pain Management, National Cancer Institute, Cairo University,Cairo,Egypt
Emad Gerges Saleh Department of Anesthesiology, Surgical ICU and Pain Management, National Cancer Institute, Cairo University, Cairo, Egypt.
Norma Osama Abdalla Department of Anesthesiology, Surgical ICU and Pain Management, National Cancer Institute, Cairo University, Cairo, Egypt.
Noha Hassan Radwan Department of Clinical Pathology and Oncological Laboratory Medicine, National Cancer Institute, Cairo, Egypt.
Ekramy Mansour Abdelghfar Department of Anesthesiology, Surgical ICU and Pain Management, National Cancer Institute, Cairo University, Cairo, Egypt.
Abstract
Background & Objectives: Stress response to extensive surgeries in cancer patients results in an imbalance between the pro-inflammatory and anti-inflammatory cytokines, besides activating an inflammatory cascade. We investigated the comparative effects of intravenous infusion of dexmedetomidine and lidocaine on proinflammatory cytokines and the stress reaction. Methodology: A prospective randomized double blind trial was performed in National Cancer Institute. 54 patients scheduled for pelvi-abdominal cancer surgery under general anesthesia were randomly allocated to three equal groups. Lidocaine group: patients received 1.5 mg/kg loading dose of lidocaine followed by 1.5 mg/kg/h infusion; Dexmedetomidine group: received a loading dose of dexmedetomidine 1 µg/kg followed by infusion of 0.5 µg/kg/h; or Saline group: received 50 ml of normal saline followed by infusion at a rate of 10 ml/h till the end of the surgery. The primary outcome was a postoperative target level of IL-6 after 24 h. Results: Immediate and 24 h postoperative IL-6 and TNFa were significantly lower in both dexmedetomidine and lidocaine groups compared to the control group (P < 0.001). Dexmedetomidine group had a significantly lower IL-6 and TNFa levels compared to lidocaine group at immediate postoperative and 24 h postoperative period (P < 0.001). Dexmedetomidine and lidocaine groups had a significantly lower lactate and insulin levels compared to the control group immediately postoperatively as well as 24 h postoperatively (P < 0.001). The dexmedetomidine group had a significantly lower lactate levels compared to the lidocaine group immediately postoperatively only. The lidocaine group had lower insulin level than the control group regarding immediate postoperative period only. Conclusion: Intraoperative infusion of dexmedetomidine or lidocaine, both attenuate the postoperative levels of proinflammatory cytokines and stress response in patients undergoing pelvi-abdominal cancer surgeries. 
Publication Details
Page(s) 5-13
Published Journal: Anaesthesia, Pain and Intensive Care, Volume: 26, Issue: 1, Year: 2022

Request the full text from PASTIC

Keywords
Lidocaine, Lidocaine, Dexmedetomidine, Surgery, Stress Response, interleukins, Tumor Necrosis Factor-a, Pelvi-abdominal cancer
0

Citations

0

Downloads

40

Views